| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.6M | +55.3% |
| R&D Expense | $160.6M | +3.4% |
| SG&A Expense | $52.3M | +4.4% |
| Operating Income | -$208.3M | -2.9% |
| Income Tax | $0 | — |
| Net Income | -$201.1M | -2.7% |
| EPS (Basic) | -$1.35 | +18.2% |
| EPS (Diluted) | -$1.35 | +18.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.0M | -65.5% |
| Current Assets | $181.3M | -14.4% |
| Total Assets | $342.7M | +15.2% |
| Current Liabilities | $37.4M | -1.4% |
| Total Liabilities | $221.9M | +53.7% |
| Stockholders' Equity | $120.9M | -21.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$162.6M | -32.3% |
| Capital Expenditures | $4.5M | -37.9% |
| Investing Cash Flow | -$108.8M | -258.9% |
| Financing Cash Flow | $151.5M | -22.6% |
| Free Cash Flow | -$167.1M | -28.4% |